Crossmark

A phase I/II trial of capecitabine combined with peginterferon α-2a in Patients with sorafenib-refractory advanced hepatocellular carcinoma

Published Online: 2014-04-16

Published Print: 2014-08

Authors

Ogasawara, Sadahisa

Chiba, Tetsuhiro

Ooka, Yoshihiko

Kanogawa, Naoya

Motoyama, Tenyu

Suzuki, Eiichiro

Tawada, Akinobu

Kanai, Fumihiko

Yokosuka, and Osamu
License Information

Text and Data Mining valid from 2014-04-16

Version of Record valid from 2014-04-16
More Information

Article History

Received: 8 February 2014

Accepted: 30 March 2014

First Online: 16 April 2014

Document is current